Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.063; wR factor = 0.134; data-to-parameter ratio = 22.9.
In the title pyrimidine-2,4-dione derivative, C 14 H 16 N 2 O 2 S, the dihedral angle between the six-membered rings is 77.81 (10) . The molecule is twisted about the C p -S (p = pyrimidine) bond, with a C-S-C-N torsion angle of À59.01 (17) . An intramolecular C-HÁ Á ÁS hydrogen bond generates an S(5) ring motif. In the crystal, bifurcated acceptor N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds generate inversion-related dimers incorporating R 2 1 (9) and R 2 2 (8) loops. These dimers are connected into a chain extending along the a-axis direction by a second pair of inversion-related N-HÁ Á ÁO hydrogen bonds, forming another R 2 2 (8) loop. The crystal structure is further stabilized by weak intermolecular C-HÁ Á Á interactions, generating a three-dimensional network.
Related literature
For the pharmacological activity of pyrimidine-2,4-dione derivatives, see: Al-Abdullah et al. (2011 ; Tanaka et al. (1995) ; Hopkins et al. (1996) ; Russ et al. (2003) ; Al-Deeb et al. (2013) ; Nencka et al. (2006) ; El-Emam et al. (2004) ; El-Brollosy et al. (2009, 2011) . For related pyrimidine-2,4-dione structures, see: Al-Omary et al. (2014) ; Wang et al. (2006) . For reference bond lengths, see: Allen et al. (1987) . For hydrogenbond motifs, see: Bernstein et al. (1995) . H atoms treated by a mixture of independent and constrained refinement Á max = 0.56 e Å À3 Á min = À0.37 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Cg1 and Cg2 are the centroids of C1-C6 and C8-C11/N1/N2 rings, respectively. Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz; (ii) Àx; Ày þ 1; Àz; (iii) Àx; y þ 1 2 ; Àz þ 1 2 ; (iv) Àx; Ày; Àz.
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 (Tanaka et al., 1995; Hopkins et al., 1996; El-Emam et al., 2004) , and HSV viruses (Russ et al., 2003) . In addition, potent anticancer activity was observed for several pyrimidine-2,4-diones (Nencka et al., 2006) . In a continuation of our interest in the chemical and pharmacological properties of pyrimidine and uracil derivatives (Al-Abdullah et al., 2011; El-Brollosy et al., 2009) , we have synthesized the title compound (I) as a potential chemotherapeutic agent.
In the title compound ( Fig. 1) , the two six-membered rings (C1-C6 and C8-C11/N1/N2) are essentially planar, with maximum deviations of -0.012 (2) Å at atom C5 and 0.020 (2) Å at atom C10, respectively. The molecule is bent at the S atom with C6-S1-C8-N1 torsion angle of -59.01 (17)°. The heterocycle containing the structural unit CON 2 H 2 CO forms a dihedral of 77.81 (10)° with the adjacent benzene ring. Bond lengths and angles in (I) show normal values (Allen et al., 1987) and are comparable with those in related structures (Al-Omary et al., 2014; El-Brollosy et al., 2011; Wang et al., 2006 ). An intramolecular C-H···S hydrogen bond generates an S(5) ring motif. In the crystal structure, bifurcated acceptor N1-H1N1···O1 and C7-H7B···O1 (Table 1) hydrogen bonds link the two adjacent molecules into centrosymmetric inversion related dimers incorparating R 2 1 (9) and R 2 2 (8) loops (Fig. 2 , Bernstein et al., 1995) . These dimers are connected into a chain extending along a-axis direction via a pair of N2-H1N2···O2 hydrogen bonds (Table 1) resulting in another R 2 2 (8) loop (Fig. 2, Bernstein et al., 1995) . The crystal structure stability is further consolidated by weak intermolecular C-H···π interactions (Table 1) involving the centroids of the six-membered C8-C11/N1/N2 (Cg1) and C1-C6 benzene (Cg2) rings.
A mixture of 6-chloro-5-propyluracil (943 mg, 0.005 mol), o-thiocresol (621 mg, 0.005 mol) and potassium hydroxide (281 mg, 0.005 mol), in ethanol (10 ml), was heated under reflux for 3 h. The solvent was then distilled off in vaccuo and the residue was washed with cold water, dried and crystallized from ethanol to yield 940 mg (68%) of the title compound (CH 2 CH 2 CH 3 ), 117.44 (Pyrimidine C-5), 125.90, 126.50, 129.88, 130.20, 133.18, 140.56 
Refinement
The nitrogen-bound H-atoms were located in a difference Fourier map and were refined freely. Other H atoms were positioned geometrically (C=H 0.93-0.97 Å) and refined using a riding model with U iso (H) = 1.2 U eq (C) or 1.5 U eq (C) for methyl H atoms. A rotating group model was used for the methyl group.
Figure 1
The molecular structure of the title compound with atom labels and 30% probability displacement ellipsoids. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
6-[(2-Methylphenyl)sulfanyl]-5-propylpyrimidine-2,4(1H,3H)-dione

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq S1 0.06364 (5) −0.09820 (10) 0.09629 (2) 0.01784 (14) (9) 0.0202 (9) −0.0015 (7) 0.0003 (7) 0.0019 (7) N2 0.0070 (7) 0.0167 (9) 0.0185 (9) −0.0019 (7) 0.0016 (6) 0.0028 (7) C1 0.0178 (10) 0.0194 (11) 0.0226 (11) −0.0012 (9) 0.0027 (9) 0.0026 (9) Geometric parameters (Å, º) S1-C8 1.763 (2) C4-H4A 0.9300 S1-C6 1.792 (2) C5-C6 1.399 (3) Symmetry codes: (i) −x+1, −y+1, −z; (ii) −x, −y+1, −z; (iii) −x, y+1/2, −z+1/2; (iv) −x, −y, −z.
